您的位置:
首页  科学研究

病原微生物研究院2021年论文

发布时间:2022-05-20 发布单位:病原微生物研究院

1.Tian, MF;Liu, WY;Li, X;Zhao, PY;Shereen, MA;Zhu, CL;Huang, SY;Liu, SY;Yu, X;Yue, MM;Pan, P;Wang, WB;Li, YK;Chen, XL;Wu, KL;Luo, Z;Zhang, QW;Wu, JG .HIF-1 alpha promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. SIGNAL TRANSDUCTION AND TARGETED THERAPY : 6 : 1. IF=18.187

2.Pan, P;Shen, MM;Yu, ZY;Ge, WW;Chen, KL;Tian, MF;Xiao, F;Wang, ZW;Wang, J;Jia, YL;Wang, WB;Wan, P;Zhang, J;Chen, WJ;Lei, ZW;Chen, X;Luo, Z;Zhang, Q;Xu, M;Li, G;Li, YK;Wu, JG .SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. NATURE COMMUNICATIONS : 12: 1 .IF=14.919

3.Li, YK; Huang, Y; Pan, P; Che, X; Zhang, YR; Zhang, YS; Amal, A; Li, X; Niu, WJ; Luo, NC; Zhang, W; Gao, DL; Tan, QP; Zhang, QW; Xing, XW; Luo, Z; Wu, JG.Sericin and sericin-derived peptide alleviate viral pathogenesis in mice though inhibiting lactate production and facilitating antiviral response. APPLIED MATERIALS TODAY 25. IF=10.041

4.Zhou, ZH;Yang, ZY;Ou, JX;Zhang, H;Zhang, QW;Dong, M;Zhang, G .Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL 19 161-167. IF=7.271

5.Liu, JB;Bodnar, BH;Meng, FZ;Khan, AI;Wang, X;Saribas, S;Wang, T;Lohani, SC;Wang, P;Wei, ZY;Luo, JJ;Zhou, LN;Wu, JG;Luo, GX;Li, QS;Hu, WH;Ho, WZ .Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. CELL AND BIOSCIENCE :11 :1. IF=7.133

6.Pan, P;Li, G;Shen, MM;Yu, ZY;Ge, WW;Lao, ZZ Fan, YH;Chen, KL;Ding, ZH;Wang, WB;Wan, P;Shereen, MA;Luo, Z;Chen, XL;Zhang, QW;Lin, LP;Wu, JG.DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction. PLOS PATHOGENS: 17: 7. IF=6.823

7.Chen, YT; Li, ZX; Pan, P; Lao, ZZ; Xu, JT; Li, ZH; Zhan, SF; Liu, XH; Wu, YN; Wang, WBA; Li, G .Cinnamic acid inhibits Zika virus by inhibiting RdRp activity. ANTIVIRAL RESEARCH. IF=5.97

8.Shang, J;Zheng, Y;Mo, JY;Wang, WB;Luo, Z;Li, YK;Chen, XL;Zhang, QW;Wu, KL;Liu, WY;Wu, JG.Sox4 represses host innate immunity to facilitate pathogen infection by hijacking the TLR signaling networks. VIRULENCE :11 :1. IF=5.882

9.Hu, DW;Wang, YC;Li, AX;Li, Q;Wu, CF;Shereen, MA;Huang, SY;Wu, KL Zhu, Y;Wang, WBA;Wu, JG .LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination. VIRULENCE :12 :1. IF=5.882

10.Lai, SY; Xu, MQ; Wang, YH; Li, RL; Xia, CA; Xia, SS; Chen, J .Site-specific SUMOylation of viral polymerase processivity factor: a way of localizingtoND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus. VIRULENCE 1212883-2901. IF=5.882

11.Feng, LY;Li, WW;Wu, XY;Li, XT;Yang, XP;Ran, YH;Wu, JG;Li, HJ.Human Cytomegalovirus UL23 Attenuates Signal Transducer and Activator of Transcription 1 Phosphorylation and Type I Interferon Response. FRONTIERS IN MICROBIOLOGY : 12. IF=5.64

12.Zhao,S;Guan,WY;Ma,K;Yan,YQ;Ou,JX;Zhang,J;Yu,ZW;Wu,JG;Zhang,QW.DevelopmentandApplicationofaFastMethodtoAcquiretheAccurateWhole-GenomeSequencesofHumanAdenoviruses.FRONTIERSINMICROBIOLOGY:12.IF=5.64

13.Tang, W; Li, YY; Song, QY; Wang, ZQ; Li, MM; Zhang, QW; Wang, Y; Ye, WC; Li, YL .Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein. JOURNAL OF VIROLOGY :95 :20. IF=5.103

14.Luo, Z;Zhu, CL;Ruan, ZH;Cui, XH;Shereen, MA;Pan, P;Huang, JT;Wang, FB;Su, HW;Xia, YC;Wu, JG.Longitudinal Characterization of Cytokine Overproduction: A Case Report in Critically Ill COVID-19 Patients With Hyperinflammation in Bronchoalveolar Lavage. FRONTIERS IN MEDICINE :8. IF=5.091

15.Yang, G;Wan, P;Xiang, Q;Huang, SY;Huang, SY;Wang, J;Wu, KL;Wu, JG E3 Ubiquitin Ligase ASB17 Promotes Apoptosis by Ubiquitylating and Degrading BCLWand MCL1. BIOLOGY-BASEL : 10: 3 .. IF=5.079

16.Chen,KL;Xiao,F;Hu,DW;Ge,WW;Tian,MF;Wang,WB;Pan,P;Wu,KL;Wu,JG.SARS-CoV-2NucleocapsidProteinInteractswithRIG-IandRepressesRIG-MediatedIFN-betaProduction.VIRUSES-BASEL:13:1.IF=5.048

17.Wang, YC; Li, Q; Hu, DW; Gao, DL; Wang, WB; Wu, KL; Wu, JG .USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination. VIRUSES-BASEL : 13 : 10. IF=5.048

18.Shereen, MA;Bashir, N;Su, R;Liu, F;Wu, KL;Luo, Z;Wu, JG .Zika virus dysregulates the expression of astrocytic genes involved in neurodevelopment. PLOS NEGLECTED TROPICAL DISEASES :15 :4. IF=4.411

19.Zhang, J;Ma, K;Wang, XY;Jiang, YB;Zhao, S;Ou, JX;Lan, WD;Guan, WY;Wu, XW;Zheng, HP;Yang, B;Wan, CS;Zhao, W;Wu, JG;Zhang, QW .Desmoglein 2Is A Receptor of Human Adenovirus Type 55 Causing Adult Severe Community-Acquired Pneumonia.VIROLOGICA SINICA. IF=4.327

20.Huang, SY;Wan, P;Huang, SY;Liu, SY;Xiang, Q;Yang, G;Shereen, MA;Pan, P;Wang, J;Liu, WY;Wu, KL;Wu, JG.The APC10 subunit of the anaphase-promoting complex/cyclosome orchestrates NLRP3 inflammasome activation during the cell cycle.FEBS LETTERS. IF=4.124

21.Li, WW; Yu, B; Zhou, JJ; Wang, YL; Xue, B; Pan, JL; Ran, YH; Yang, XP; Wang, XP; Yang, F; Li, HJ .Genetic diversity and epidemiology of human rhinovirus among children with severe acute respiratory tract infection in Guangzhou, China.VIROLOGY JOURNAL : 18 : 1. IF=4.099

22.Ou, Junxian;Zhou, Zhonghua;Dai, Ruixue;Zhang, Jing;Zhao, Shan;Wu, Xiaowei;Lan, Wendong;Ren, Yi;Cui, Lilian;Lan, Qiaoshuai;Lu, Lu;Seto, Donald;Chodosh, James;Wu, Jianguo;Zhang, Gong;Zhang, Qiwei.V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.Journal of virology 9516. IF=5.103

23.Jia, Hong-Ling;Li, Peng;Liu, Hong-Jie;Zhong, Jia-Yong;Qin, Peng-Zhe;Su, Wen-Zhe;Zheng, Ying-Feng;Li, Kui-Biao;Zeng, Qing;Li, Jin-Hui;Li, Li-Zhong;Cao, Lan;Wu, Ji-Bin;Chen, Yi-Yun;Jia, Lei-Li;Song, Hong-Bin;Zhang, Qi-Wei;Yang, Guang;Jing, Chun-Xia;Bo, Xiao-Chen;Zhang, Zhou-Bin;Di, Biao;Xiao, Chuan-Le;Ni, Ming.Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.Journal of clinical microbiology. IF=5.948